ArticleNAM journal2026
ASPIS Academy: A blueprint for building early-career researcher networks to advance NAM-based risk assessment.
Article in NAM journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemical risk assessment is moving away from traditional animal-based testing toward New Approach Methodologies (NAMs) that are more human-relevant, efficient, and aligned with the replacement, reduction, and refinement of animal use. This transition depends not only on new methods and technologies, but also on the researchers who will develop, apply, and promote them. Early-career researchers (ECRs) are central to this effort, yet they often work within fragmented professional networks and have limited opportunities for mentoring, visibility, and leadership. The ASPIS Academy (AA) was established within the ASPIS cluster, comprising the EU Horizon 2020-funded projects ONTOX, RISK-HUNT3R, and PrecisionTox, to support ECRs working on NAM-based chemical risk assessment. Built and coordinated by ECRs with support from senior advisors, AA evolved from an initial idea into an operational network offering training, mentoring, mirroring, twinning, communication, dissemination, and collaboration activities. Its development was shaped not only by strategic planning, but also by the practical realities of voluntary coordination and the changing needs of ECRs across large multidisciplinary consortia. This manuscript presents the establishment, growth, and legacy planning of AA as a case study for building ECR networks in collaborative research environments. We describe the decisions, challenges, lessons learned, and activities that helped the network become useful to its community and provide a practical blueprint for other consortia seeking to support the next generation of NAM scientists. The AA experience demonstrates that empowering ECRs to lead can strengthen scientific communities and accelerate the uptake of NAMs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.